The products, which are widely available in the U.S. and the European Union, include 23 medicines and vaccines that treat infectious diseases, some cancers and rare and inflammatory conditions.
and treatment, at not-for-profit prices in some of the world's poorest countries.
Company spokeswoman Pam Eisele said only a small number of the medicines and vaccines are currently available in the 45 countries. "What we discovered through the pandemic was that supply was not enough to resolve the issues that these countries are having," Pfizer Chairman and CEO Albert Bourla said Wednesday during a talk at Davos.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer CEO Says He ‘Wouldn't Worry Much' About Monkeypox; Cuts Drug Prices for Low-Income CountriesPfizer’s CEO said Wednesday that he “wouldn’t worry much” about a recent monkeypox outbreak that has seen cases surge in non-endemic countries.
Read more »
Pfizer to Offer Low-Cost Medicines, Vaccines to 45 Lower-Income NationsA company spokeswoman says only a small number of the medicines and vaccines are currently available in those countries.
Read more »
'Too Little, Too Late,' Campaigners Say as Pfizer Pledges Lower Vaccine Costs for Poor Nations'We shouldn't hail pandemic profiteers as heroes, even when they make qualified gestures like this.' —peoplesvaccine
Read more »
Pfizer to sell all its patented drugs at nonprofit price in low-income countriesPfizer Inc will make all of its patented medicines including COVID-19 treatment Paxlovid and big-selling breast cancer drug Ibrance available at a not-for-profit price to 45 of the world's poorest countries, the drugmaker said on Wednesday.
Read more »
Pfizer Offers Low-Cost Drugs And Vaccines—Including Covid Treatments—To World’s Poorest CountriesI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Read more »
Pfizer: 3 COVID vaccine doses are 80 percent effective for kids 5 and underThree doses of the Pfizer-BioNTech COVID-19 vaccine were roughly 80 percent effective at preventing infections for children ages 6 months to 5 years old, according to trial data Pfizer released Monday.
Read more »